Newsflash:
- Sanofi Highlights Positive PhIII Study for Myelofibrosis Contender
- Prescription Painkillers Linked to Erectile Dysfunction
- Melanoma Treatment Harnesses Immune System to Combat Cancer Cells
- Gout: No Help From Vitamin C
- FDA Okays New Drug for Castration-Resistant Prostate Cancer
- FDA Approves Genetic Test for Lung Cancer Drug
Novo Nordisk Warns FDA of Biosimilar Delivery Safety Fears
In-PharmaTechnologist (04/17/12) Taylor, Nick
Novo Nordisk has told the FDA that allowing alternative delivery devices for biosimilars creates "significant safety implications." FDA draft guidance released earlier in the year allows biosimilars to use different drug delivery devices than their reference products.
Abstract News © Copyright 2011
INFORMATION, INC.
Sponsor Highlights
Our Sponsors:
Sitemap
© Pharmacist e-Link
